Association studies of the copy-number variable β-defensin cluster on 8p23.1 in adenocarcinoma and chronic pancreatitis

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Taudien, Stefan ^a   Gäbel, Gabor ^b   Kuss, Oliver ^c   Groth, Marco ^a   Grützmann, Robert ^c   Huse, Klaus ^a   Kluttig, Alexander ^c   Wolf, Andreas ^d   Nothnagel, Michael ^d,f   Rosenstiel, Philip ^d   Greiser, Karin Halina ^c,e   Werdan, Karl ^c   Krawczak, Michael ^d   Pilarsky, Christian ^b   Platzer, Matthias ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chronic pancreatitis; Copy number variation; Defensins; Pancreatic ductal adenocarcinoma; Single nucleotide variants

Indexed keywords

MAIZE STREAK VIRUS;

BETA DEFENSIN;

ADENOCARCINOMA; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 8; CHRONIC PANCREATITIS; COHORT ANALYSIS; COPY NUMBER VARIATION; GENETICS; HUMAN; PANCREAS CARCINOMA;

ADENOCARCINOMA; BETA-DEFENSINS; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; HUMANS; PANCREATITIS, CHRONIC;

EID: 84868663935     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-629     Document Type: Article

References (45)

1. Managing acute and chronic pancreatitis. Skipworth JR, Shankar A, Pereira SP, Practitioner 2010 254 23 27 22 21306035
2. Development of chronic pancreatitis from acute pancreatitis: a pathogenetic concept. Kloppel G, Maillet B, Zentralbl Chir 1995 120 274 277 7778338
3. Chronic pancreatitis: recent advances and ongoing challenges. Ahmed SA, Wray C, Rilo HL, Choe KA, Gelrud A, Howington JA, Lowy AM, Matthews JB, Curr Probl Surg 2006 43 127 238 10.1067/j.cpsurg.2005.12.004 16530053
4. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R, Best Pract Res Clin Gastroenterol 2010 24 349 358 10.1016/j.bpg.2010.02.007 20510834
5. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
6. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Raptis DA, Fessas C, Belasyse-Smith P, Kurzawinski TR, Surgeon 2010 8 239 246 10.1016/j.surge.2010.03.001 20709279
7. Immunology: Peptide gets in shape for self-defence. Lehrer RI, Nature 2011 469 309 310 10.1038/469309a 21248835
8. Antimicrobial peptides in lung inflammation. Beisswenger C, Bals R, Chem Immunol Allergy 2005 86 55 71 15976488
9. Beta-defensins: what are they REALLY doing in the oral cavity? Diamond G, Ryan L, Oral Dis 2011 17 7 628 635 10.1111/j.1601-0825.2011.01799.x 21332602
10. Antimicrobial peptides: general overview and clinical implications in human health and disease. Guani-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Teran LM, Clin Immunol 2010 135 1 11 10.1016/j.clim.2009.12.004 20116332
11. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Herr C, Shaykhiev R, Bals R, Expert Opin Biol Ther 2007 7 1449 1461 10.1517/14712598.7.9.1449 17727333
12. Copy number variation of beta-defensins and relevance to disease. Hollox EJ, Cytogenet Genome Res 2008 123 148 155 10.1159/000184702 19287149
13. Gene expression of human beta-defensins in healthy and inflamed human dental pulps. Paris S, Wolgin M, Kielbassa AM, Pries A, Zakrzewicz A, J Endod 2009 35 520 523 10.1016/j.joen.2008.12.015 19345797
14. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Hollox EJ, Armour JA, Barber JC, Am J Hum Genet 2003 73 591 600 10.1086/378157 12916016
15. Polymorphic segmental duplications at 8p23.1 challenge the determination of individual defensin gene repertoires and the assembly of a contiguous human reference sequence. Taudien S, Galgoczy P, Huse K, Reichwald K, Schilhabel M, Szafranski K, Shimizu A, Asakawa S, Frankish A, Loncarevic IF, et al. BMC Genomics 2004 5 92 10.1186/1471-2164-5-92 15588320
16. High-resolution mapping of the 8p23.1 beta-defensin cluster reveals strictly concordant copy number variation of all genes. Groth M, Szafranski K, Taudien S, Huse K, Mueller O, Rosenstiel P, Nygren AO, Schreiber S, Birkenmeier G, Platzer M, Hum Mutat 2008 29 1247 1254 10.1002/humu.20751 18470942
17. Both copy number and sequence variations affect expression of human DEFB4. Groth M, Wiegand C, Szafranski K, Huse K, Kramer M, Rosenstiel P, Schreiber S, Norgauer J, Platzer M, Genes Immun 2010 11 458 466 10.1038/gene.2010.19 20445567
18. A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia. Hardwick RJ, Machado LR, Zuccherato LW, Antolinos S, Xue Y, Shawa N, Gilman RH, Cabrera L, Berg DE, Tyler-Smith C, et al. Hum Mutat 2011 32 743 750 10.1002/humu.21491 21387465
19. Haplotyping and copy number estimation of the highly polymorphic human beta-defensin locus on 8p23 by 454 amplicon sequencing. Taudien S, Groth M, Huse K, Petzold A, Szafranski K, Hampe J, Rosenstiel P, Schreiber S, Platzer M, BMC Genomics 2010 11 252 10.1186/1471-2164-11-252 20403190
20. Comprehensive assessment of sequence variation within the copy number variable defensin cluster on 8p23 by target enriched in-depth 454 sequencing. Taudien S, Szafranski K, Felder M, Groth M, Huse K, Raffaelli F, Petzold A, Zhang X, Rosenstiel P, Hampe J, et al. BMC Genomics 2011 12 243 10.1186/1471-2164-12-243 21592371
21. Psoriasis is associated with increased beta-defensin genomic copy number. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PC, Traupe H, de Jongh G, den Heijer M, et al. Nat Genet 2008 40 23 25 10.1038/ng.2007.48 18059266
22. Complex SNP-related sequence variation in segmental genome duplications. Fredman D, White SJ, Potter S, Eichler EE, Den Dunnen JT, Brookes AJ, Nat Genet 2004 36 861 866 10.1038/ng1401 15247918
23. Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats. Armour JA, Palla R, Zeeuwen PL, den Heijer M, Schalkwijk J, Hollox EJ, Nucleic Acids Res 2007 35 19 10.1093/nar/gkl1089 17175532
24. Detection of aneuploidies by paralogous sequence quantification. Deutsch S, Choudhury U, Merla G, Howald C, Sylvan A, Antonarakis SE, J Med Genet 2004 41 908 915 10.1136/jmg.2004.023184 15591276
25. Rapid detection of trisomy 21 by homologous gene quantitative PCR (HGQ-PCR). Lee HH, Chang JG, Lin SP, Chao HT, Yang ML, Ng HT, Hum Genet 1997 99 364 367 10.1007/s004390050373 9050924
26. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G, Nucleic Acids Res 2002 30 57 10.1093/nar/gnf056 12060695
27. Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease. Aldhous MC, Abu Bakar S, Prescott NJ, Palla R, Soo K, Mansfield JC, Mathew CG, Satsangi J, Armour JA, Hum Mol Genet 2010 19 4930 4938 10.1093/hmg/ddq411 20858604
28. Comparison of multiplex ligation-dependent probe amplification and real-time PCR accuracy for gene copy number quantification using the beta-defensin locus. Perne A, Zhang X, Lehmann L, Groth M, Stuber F, Book M, Biotechniques 2009 47 1023 1028 10.2144/000113300 20041854
29. Increased genomic copy number of DEFA1/DEFA3 is associated with susceptibility to severe sepsis in Chinese Han population. Chen Q, Hakimi M, Wu S, Jin Y, Cheng B, Wang H, Xie G, Ganz T, Linzmeier RM, Fang X, Anesthesiology 2010 112 1428 1434 10.1097/ALN.0b013e3181d968eb 20502117
30. Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease. Aldhous MC, Noble CL, Satsangi J, PLoS One 2009 4 6285 10.1371/journal.pone.0006285 19617917
31. Association of Higher DEFB4 Genomic Copy Number With Crohn's Disease. Bentley RW, Pearson J, Gearry RB, Barclay ML, McKinney C, Merriman TR, Roberts RL, Am J Gastroenterol 2009 105 2 354 359 19809410
32. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Reinisch W, Teml A, Schwab M, Lichter P, et al. Am J Hum Genet 2006 79 439 448 10.1086/505915 16909382
33. Genetic variants of the copy number polymorphic beta-defensin locus are associated with sporadic prostate cancer. Huse K, Taudien S, Groth M, Rosenstiel P, Szafranski K, Hiller M, Hampe J, Junker K, Schubert J, Schreiber S, et al. Tumour Biol 2008 29 83 92 10.1159/000135688 18515986
34. Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study. Greiser KH, Kluttig A, Schumann B, Kors JA, Swenne CA, Kuss O, Werdan K, Haerting J, BMC Cardiovasc Disord 2005 5 33 10.1186/1471-2261-5-33 16283930
35. Comprehensive proteomic analysis of human pancreatic juice. Gronborg M, Bunkenborg J, Kristiansen TZ, Jensen ON, Yeo CJ, Hruban RH, Maitra A, Goggins MG, Pandey A, J Proteome Res 2004 3 1042 1055 10.1021/pr0499085 15473694
36. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L, N Engl J Med 1993 328 1433 1437 10.1056/NEJM199305203282001 8479461
37. Epidemiology of pancreatic cancer: an overview. Raimondi S, Maisonneuve P, Lowenfels AB, Nat Rev Gastroenterol Hepatol 2009 6 699 708 10.1038/nrgastro.2009.177 19806144
38. Pancreatitis in inflammatory bowel diseases. Pitchumoni CS, Rubin A, Das K, J Clin Gastroenterol 2010 44 246 253 10.1097/MCG.0b013e3181cadbe1 20087199
39. Beta-defensins and Crohn's disease: confusion from counting copies. Hollox EJ, Am J Gastroenterol 2010 105 360 362 10.1038/ajg.2009.573 20139874
40. Alcoholic pancreatitis: mechanisms of viral infections as cofactors in the development of acute and chronic pancreatitis and fibrosis. Jerrells TR, Vidlak D, Strachota JM, J Leukoc Biol 2007 81 430 439 10.1189/jlb.1004622 17095612
41. Polymorphisms of beta defensins are associated with the risk of severe acute pancreatitis. Tiszlavicz Z, Szabolcs A, Takacs T, Farkas G, Kovacs-Nagy R, Szantai E, Sasvari-Szekely M, Mandi Y, Pancreatology 2010 10 483 490 10.1159/000276987 20720450
42. Inflammatory mechanisms contributing to pancreatic cancer development. Farrow B, Sugiyama Y, Chen A, Uffort E, Nealon W, Mark Evers B, Ann Surg 2004 239 763 769 discussion 769-771 10.1097/01.sla.0000128681.76786.07 15166955
43. Inflammation and cancer. Coussens LM, Werb Z, Nature 2002 420 860 867 10.1038/nature01322 12490959
44. Defensins as anti-inflammatory compounds and mucosal adjuvants. Kohlgraf KG, Pingel LC, Dietrich DE, Brogden KA, Future Microbiol 2010 5 99 113 10.2217/fmb.09.104 20020832
45. Defensins: antimicrobial peptides of innate immunity. Ganz T, Nat Rev Immunol 2003 3 710 720 10.1038/nri1180 12949495